Novozymes appoints new EVP Strategy

Amy Byrick will assume her new position of Executive Vice President of Strategy and Business Transformation at Novozymes in April 2021, reporting to President and CEO Ester Baiget.

Baiget said: “Amy has strong cross-functional leadership capabilities and a solid track-record of driving operational simplification with a focus on empowerment and agile cultures and mindsets. She has the right strategic and commercial profile with extensive market-driven business experience. Her capabilities will be instrumental in our collective effort to become a more customer-centric company with better commercial capabilities and a portfolio diversification that drives higher, sustainable growth. I’m confident Amy is the right person to advance our strategy and transform our business for the world of tomorrow.”

Byrick joins Novozymes from DuPont Nutrition and Biosciences, where she led the Global Food and Beverage business. Prior to her time at DuPont, Byrick spent more than a decade at Amcor holding various strategic, marketing and general management positions. She holds both Canadian and French nationalities and resides in Denmark. She holds a bachelor’s degree in Chemical Engineering from Queen’s University and an MBA from INSEAD.

Byrick said: “I’m very excited to join Novozymes. The company’s unique capabilities and technology, and its aspiration to enable sustainable solutions to meet evolving global needs, is something that I find immensely inspiring. I look forward to joining the team and growing the business.”

Thomas Videbæk, interim EVP of Strategy and Business Transformation, will transition this role to Byrick. The aim is for the transition to take place during the second quarter of 2021. Thomas will continue in his role as interim EVP of People, Sustainability and Brand until his successor is appointed and established in the role.